Skip to content
PeptideInfowiki
Index by category›

Reproductive & Hormonal

Salmon calcitonin

Calcitonin salmon; Miacalcin

1 min read · Updated July 27, 2026 · 3 references

Curated by PeptideInfo Wikilast reviewed how we verify

Explored forApproved peptide medicines — verification pilot
In brief · TL;DR
Approved medicine· US

A synthetic salmon calcitonin medicine with limited, indication-specific FDA uses.

Evidence: Regulator-approved drug with human trial evidence.

Approved in: FDA (United States; restricted indication set in current Miacalcin label)

  • A synthetic salmon calcitonin medicine with limited, indication-specific FDA uses.
  • Calcitonin receptor activation reduces osteoclast-mediated bone resorption and lowers serum calcium.
  • The label limits use because fracture-reduction efficacy has not been demonstrated and meta-analysis identified a possible increased malignancy risk; hypersensitivity and hypocalcemia also require attention.
↓ Read the full referenced entry below

A synthetic salmon calcitonin medicine with limited, indication-specific FDA uses.

Overview

A synthetic salmon calcitonin medicine with limited, indication-specific FDA uses.

Primary regulatory source

This is an educational reference, not individual medical advice. Use requires a prescriber and indication-specific monitoring.

Identity and mechanism

Calcitonin receptor activation reduces osteoclast-mediated bone resorption and lowers serum calcium.

PubChem CID 16220016; C145H240N44O48S2; 3431.9 Da.

Regulatory label facts

FDA (United States; restricted indication set in current Miacalcin label).

The dose below reproduces a regulator-approved label; it is not a treatment recommendation.

Safety boundary

The label limits use because fracture-reduction efficacy has not been demonstrated and meta-analysis identified a possible increased malignancy risk; hypersensitivity and hypocalcemia also require attention.

This is an educational reference, not individual medical advice. Use requires a prescriber and indication-specific monitoring.

References

  1. 1.
    Salmon calcitonin — Primary regulatory source source
  2. 2.
    Salmon calcitonin — PubChem compound record source
  3. 3.
    Salmon calcitonin — Human study source

Frequently asked questions

What is Salmon calcitonin?
A synthetic salmon calcitonin medicine with limited, indication-specific FDA uses.
Is Salmon calcitonin approved as a medicine, and where?
It is an approved prescription medicine, but where it is approved matters: FDA (United States; restricted indication set in current Miacalcin label). It should only be used under medical supervision.
What is Salmon calcitonin studied for?
Salmon calcitonin is most often discussed in the context of approved peptide medicines — verification pilot. Being studied for an area does not mean it is proven or approved for it.
Does Salmon calcitonin have human clinical trials?
Yes. Salmon calcitonin has been studied in human clinical trials and is an approved medicine in at least some regions.

Educational disclaimer. This article summarizes published research for informational purposes and is not medical advice. Salmon calcitonin is an approved medicine within the stated approval scope (FDA (United States; restricted indication set in current Miacalcin label)) and must only be used under medical supervision; research-grade or unprescribed material is not a lawful substitute. Consult a qualified healthcare professional before making health decisions.

Related in Reproductive & Hormonal